Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Eli Lilly and Company - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
LLY
New York
2834
www.lilly.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Eli Lilly and Company
Q4 2024 Eli Lilly and Co Earnings Call
- Feb 7th, 2025 7:37 am
Eli Lilly and Co (LLY) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...
- Feb 7th, 2025 7:17 am
Stock Market Today: Dow Jones Dives As Nvidia Rises On DeepSeek Ban Report; Cathie Wood Stock Crashes On Earnings (Live Coverage)
- Feb 6th, 2025 9:13 pm
Eli Lilly Jumps, Reversing Its Weight-Loss Setback, On A Strong 2025 Outlook
- Feb 6th, 2025 9:04 pm
Viking Therapeutics Plunged 6% On Its Earnings Report. Here's Why.
- Feb 6th, 2025 9:02 pm
Sector Update: Health Care Stocks Slide Late Afternoon
- Feb 6th, 2025 8:59 pm
Eli Lilly (LLY) Q4 2024 Earnings Call Transcript
- Feb 6th, 2025 8:45 pm
Eli Lilly Fourth-Quarter Sales Meet Views; Reiterates 2025 Revenue Forecast
- Feb 6th, 2025 6:07 pm
Why Eli Lilly Stock Popped on Thursday
- Feb 6th, 2025 4:29 pm
Eli Lilly, Bristol Myers Squibb, Peloton: Market Minute
- Feb 6th, 2025 4:27 pm
Eli Lilly Up 13.3% in 2025: Stock Soars as New Breakthroughs Set to Fuel Explosive Growth
- Feb 6th, 2025 4:21 pm
The Obesity Market Is Growing Just Fine. But Investors Want to Know What’s Next
- Feb 6th, 2025 4:16 pm
Compared to Estimates, Lilly (LLY) Q4 Earnings: A Look at Key Metrics
- Feb 6th, 2025 4:00 pm
Zepbound sales keep soaring, even as weight loss drug growth slows
- Feb 6th, 2025 3:58 pm
Weekly Jobless Claims Exceed Expectations
- Feb 6th, 2025 3:49 pm
LLY's Q4 Earnings Beat, Mounjaro, Zepbound Sales Fall Shy of Estimates
- Feb 6th, 2025 3:47 pm
Pre-Markets Higher on Easy Jobless Claims, Q4 Earnings
- Feb 6th, 2025 3:27 pm
Eli Lilly's Q4 results beat Wall Street estimates
- Feb 6th, 2025 3:11 pm
Eli Lilly’s Disappointing Quarter Was Already Baked In
- Feb 6th, 2025 2:56 pm
Diabetes and obesity drugs fuel Eli Lilly profit in the final quarter of 2024
- Feb 6th, 2025 2:22 pm
Scroll